Skip to main content

GNTA · Genenta Science S.p.A.

Track GNTA — free
$0.68 -0.02 (-3.00%) At close · Nov 5
Market Cap
$47.49M
Shares
48.22M
Volume · Nov 5 155.3K Avg daily vol (3M) 84.87K

Price & Indicators

Drag to pan · scroll to zoom
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$0.68 Open$0.67 Day$0.56–0.68 52W close$0.58–2.46 Avg vol 30d120K Short int108K · 0.2% of shares · 2.1d Short vol37% DataDec 2021–Nov 2026

Latest documents

2026
Nov 2
Current report 6-K
Current report

Genenta Science S.p.A. will operate as Saentra Forge, with its ADSs expected to begin trading under ticker symbol “SAEN” on November 4, 2026, subject to final Nasdaq confirmation. The Board approved both changes on October 20, 2026.

Oct 22
Current report 6-K
Current report

On October 19, 2026, the Tribunal of Milan suspended Genenta Science S.p.A.’s resolution appointing its Board of Directors, causing the prior Board to resume in a prorogatio regime; the company plans to appeal.

Oct 21
Current report 6-K
Current report

Genenta Science S.p.A. received Nasdaq’s minimum bid price deficiency notice after its ADS closing bid remained below $1.00 per ADS for 30 consecutive business days. Nasdaq granted 180 calendar days, until April 14, 2027, to regain compliance.

Oct 13
Current report 6-K
Current report

Genenta Science S.p.A.’s shareholders did not approve the proposed change of its legal name to Saentra Forge S.p.A. on October 8, 2026, so the registered name remains unchanged. The company continues pursuing its strategic transition toward acquiring established industrial businesses.

Oct 7
Current report 6-K
Current report

Genenta Science S.p.A.’s capital increase for its A.T.C. S.r.l. acquisition remains effective after the Court of Milan denied minority shareholders’ interim-suspension application in an order dated October 2, 2026; the merits case remains pending and the order may be appealed.

All documents

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
—
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+7.9%
Year over year · more shares
Price change (1Y)
-72.4%
Trailing year
Short interest
0.2%
Latest settlement · 2.1 days to cover
View all 125 metrics

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Neutral Momentum Neutral Sentiment Neutral Fundamentals Limited Quant / Vol Very High
Market backdrop VIX 28.2 · fear Equity put/call 0.89
Technical
price trend
Neutral
50 / 200-day cross No cross
Price vs 200-day avg −34%
below
Price vs 50-day avg −11%
below
RSI (14) 47
neutral
MACD trend Positive
52-week position 5%
near low
Volume (OBV) Bullish div.
accumulating
Momentum
relative strength
Neutral
1-month return −4%
trailing
6-month return +8%
trailing
YTD return −54%
this year
Relative strength +9%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $1 › 200d $1 — 200d above 50d
Institutional flow Distributing
5 of 9 funds reported for Sep 30 · net -35.5K sh shares · +1 new
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
0.22% of shares out · ▼ -1.8% MoM · 2.1 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
9 holders — mid 3-yr range
Squeeze score 49
elevated · 0–100
Fundamentals
Limited
Not enough data for a confident read.
Quant / Vol
risk profile
Very High
Volatility 131%
annualized · 1-yr
Max drawdown −76%
past year
ATR 14.6%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Neutral
3 · 2 · 2
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−34% Bearish
Price vs 50-day avg
−11% Bearish
RSI (14)
47 Neutral
MACD trend
Positive Bullish
52-week position
5% Bearish
Volume (OBV)
Bullish div. Bullish
Market signals — smart money & positioning
Mixed
Trend (MA cross) No cross
50d $1 › 200d $1 — 200d above 50d
Institutional flow Distributing
5 of 9 funds reported for Sep 30 · net -35.5K sh shares · +1 new
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
0.22% of shares out · ▼ -1.8% MoM · 2.1 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
9 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $1 Now $1 · 5% Range high $2
vs 200-day avg -34% vs 50-day avg -11%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Conglomerates — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
GNTA
Genenta Science S.p.A.
this stock
$47.49M -54.4% — — 0.2%
HTHIY
Hitachi Ltd
$126.67B -8.9% — — 0.1%
ITOCF
Itochu Corp
$104.83B +20.0% — — 0.2%
MMM
3M Co
$97.03B +15.6% +1.5% 28.0 1.9%
HON
Honeywell International Inc
$68.48B — +12.9% — 2.3%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
9
% held
1.4%
Reported
5 of 9
Top holder
Eurizon Capital SGR S.p.A.
Held Float
View
Held by Funds
Fund positions
1
View
Short & Settlement
Short Interest Falling
Shares short
108.1K
Days to cover
2.1d
Change
-2.0K sh
View
Short Volume
Short vol %
37%
As of
Nov 3, 2026
Short Total
View
Fails to Deliver
FTD shares
1.2K
Value
$833
As of
Sep 17, 2026
View
Off-Exchange
Off-exchange %
61.7%
Week of
Sep 28, 2026
Off-exch Lit
View
Financials
Financials
Net income (FY)
EUR -6.5M
EPS diluted
EUR -0.33
View
Filings
SEC Filings
Latest
6-K
Filed
Nov 2, 2026
This year
24

Genenta Science S.p.A. will operate as Saentra Forge, with its ADSs expected to begin trading under ticker symbol “SAEN” on November 4, 2026, subject to final Nasdaq confirmation. The Board approved both changes on October 20, 2026.

View
Earnings & Events
Investor Relations
Latest news
Genenta Unveils Saentra Forge as…
Published
Nov 2, 2026
View

Performance

5D 20D 120D MTD YTD
GNTA +9.5% -4.4% +8.1% +9.8% -54.4%
SPY -4.7% -5.3% -0.8% -3.0% +7.5%
vs SPY +14.3% +0.9% +9.0% +12.8% -61.9%
Key facts CIK 1838716 CUSIP 36870W100 13F (30d) 4 filings 4 filers Visit website Investor relations